Joel W. Hay

Economics, Econometrics and FinanceMedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection”.

Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection

Clinical Microbiology and Infection(2021)10.1016/j.cmi.2021.04.004

N/A

0DataRank · unranked

34 citations

Cynthia L. Gong, Matthew M. Hitchcock, Marisa Holubar, Stanley C. Deresinski, Joel W. Hay +1 more

Geographic variation in the use of continuous outpatient inotrope infusion therapy and beta blockers

IJC Heart & Vasculature(2022)10.1016/j.ijcha.2021.100948

N/A

0DataRank · unranked

5 citations

Jeffrey Tran, Nadine Zawadzki, Roy S. Zawadzki, Jennifer M. McLeod, Michael Fong +4 more